A new study sheds light on ventilator-induced lung injury, a complication that gained increased attention during the COVID-19 pandemic, which led to a surge in patients requiring mechanical ...

Positive results from the Bleomycin Pulmonary Fibrosis mouse model in vivo study attributing Thykamine with anti-fibrotic effects in lungs Compelling results compared ...

This novel finding, reported in the journal Nature Medicine, is important because, despite significant advances to reveal the pathological mechanisms of persistent fibrosis, effective treatment ...

: (A) Representative images of S1pr3 immunofluorescence staining (upper panel, scale bar = 50 μm), HE staining (middle panel, scale bar = 100 μm), and Masson's trichrome staining (lower panel, scale ...

Nerandomilast improved FVC in the FIBRONEER-ILD trial, meeting its primary end point in patients with progressive pulmonary fibrosis. Safety and tolerability results were consistent with previous ...

VIENNA — Treatment with a novel lysophosphatidic acid receptor 1 (LPA1) antagonist was associated with significant changes in baseline biomarkers of disease in adults with pulmonary fibrosis, based on ...

Panelists discuss how progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF), though distinct in etiology, share a common trajectory of irreversible lung scarring and functional ...

When appropriate, surgery remains the most effective treatment option for non-small cell lung cancer (NSCLC), including for patients with COPD, said Friedberg, professor in the Department of Thoracic ...

Medical science has long been on the hunt for a deeper understanding of the devastating scarring of the body's organs known as fibrosis, which leads to irrevocable loss of function. Fibrosis refers to ...

Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD); (OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to fibroinflammatory diseases, today announced ...